amantadine has been researched along with Hepatocellular Carcinoma in 11 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine treatment also reduced Bcl‑2 and increased the Bax protein and mRNA levels." | 1.42 | Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro. ( Chong, Z; Fang, D; Feng, D; Lan, Z; Liu, C; Zang, W; Zhou, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, Z | 1 |
| Chong, Z | 1 |
| Liu, C | 1 |
| Feng, D | 1 |
| Fang, D | 1 |
| Zang, W | 1 |
| Zhou, J | 1 |
| Griffin, S | 2 |
| Stgelais, C | 1 |
| Owsianka, AM | 1 |
| Patel, AH | 1 |
| Rowlands, D | 1 |
| Harris, M | 2 |
| Foster, TL | 1 |
| Verow, M | 1 |
| Wozniak, AL | 1 |
| Bentham, MJ | 1 |
| Thompson, J | 1 |
| Atkins, E | 1 |
| Weinman, SA | 1 |
| Fishwick, C | 1 |
| Foster, R | 1 |
| Gervais, A | 1 |
| Leroy, V | 1 |
| Hilleret, MN | 1 |
| Asselah, T | 1 |
| Griffin, SD | 1 |
| Beales, LP | 1 |
| Clarke, DS | 1 |
| Worsfold, O | 1 |
| Evans, SD | 1 |
| Jaeger, J | 1 |
| Harris, MP | 1 |
| Rowlands, DJ | 1 |
| Kanda, T | 1 |
| Yokosuka, O | 1 |
| Imazeki, F | 1 |
| Fujiwara, K | 1 |
| Nagao, K | 1 |
| Saisho, H | 1 |
| Pol, S | 1 |
| Fontaine, H | 1 |
| Vallet-Pichard, A | 1 |
| Chung, RT | 1 |
| He, W | 1 |
| Saquib, A | 1 |
| Contreras, AM | 1 |
| Xavier, RJ | 1 |
| Chawla, A | 1 |
| Wang, TC | 1 |
| Schmidt, EV | 1 |
| Hortin, G | 1 |
| Strauss, AW | 1 |
4 reviews available for amantadine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
[Chronic hepatitis C in HIV-HCV coinfected patients].
Topics: Adult; Age Factors; Amantadine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Carcinoma, | 2002 |
[Evaluation of response to treatment in chronic hepatitis C].
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Biopsy; Carcinoma, Hepatocellular; Clinical Enzy | 2002 |
[Chronic hepatitis C: what to do if the first treatment failed?].
Topics: Amantadine; Animals; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Ethanol | 2002 |
[Treatments for hepatitis virus C infections].
Topics: Amantadine; Antiviral Agents; Carcinoma, Hepatocellular; Hepatitis C; Humans; Interferon-alpha; Live | 2001 |
7 other studies available for amantadine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Amantadine inhibits cellular proliferation and induces the apoptosis of hepatocellular cancer cells in vitro.
Topics: Amantadine; Antineoplastic Agents; Antiviral Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycl | 2015 |
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Ce | 2008 |
Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
Topics: Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug | 2011 |
The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.
Topics: Amantadine; Antiviral Agents; Carcinoma, Hepatocellular; Humans; Ion Channels; Lipid Bilayers; Membr | 2003 |
Amantadine inhibits hepatitis A virus internal ribosomal entry site-mediated translation in human hepatoma cells.
Topics: Amantadine; Bacteriophage T7; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Respo | 2005 |
Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
Topics: Amantadine; Animals; Antiviral Agents; Bacteriophage T7; Carcinoma, Hepatocellular; Chlorocebus aeth | 2001 |
Effects of acidotropic compounds on the secretory pathway: inhibition of secretion and processing of the third and fourth components of complement.
Topics: Amantadine; Benzamidines; Carcinoma, Hepatocellular; Cell Line; Chloroquine; Complement C3; Compleme | 1986 |